Quantum BioPharma Signs Study Start-Up Deal for Lucid-MS Phase 2 Trial
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's PPD to commence its FDA-cleared Phase 2 trial of Lucid-MS for progressive MS.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.